The following were reviewed as part of this investigation: patient severity, applicable previous investigation(s), sample analysis, applicable fmea documents, and labeling.Based on a review of this information, the following was concluded: the complaint that the dilator was not removed from the powerglide catheter appeared to be associated with use.Two photographs were provided for investigation.One photo showed the powerglide catheter with the dilator connected to the catheter.The guidewire was also shown in its hoop.One photo showed a portion of the instructions for use (ifu).The ifu states, ¿remove the dilator and guidewire, leaving the catheter positioned in the vasculature.Caution: leaving dilator in catheter could result in patient discomfort and reduced catheter performance (e.G.Occlusion, aspiration, and infusion).¿ it was reported that fluid could not be injected or aspirated, and it was observed that the dilator had been left inside the catheter.The reported event appeared to be associated with use of the device.A lot history review (lhr) review is not possible, as no manufacturing lot number has been provided by the complainant.
|